Events

6 Events Reimagining Women’s Health this Autumn — from Patient Care to Clinical Innovation

This autumn, a number of events across the UK and Europe will put conversations about women’s health centre stage.

Women’s health has historically been under-researched, underfunded and, in many cases, poorly understood. But this autumn, a number of events across the UK and Europe will put these conversations centre stage, bringing together patients, clinicians, researchers, advocates, founders and investors who want to change the status quo. 

Several dedicated events will focus entirely on women’s experiences and healthcare needs, while others feature specific sessions examining women’s health through the lens of medical cannabis, mental health or emerging therapeutics.

Here’s what’s coming up. 

1. Women’s Health Week Europe — 7–8 October, London

Best for: Founders, investors, healthcare leaders, researchers and organisations working across the women’s health ecosystem.

Women’s Health Week Europe is the broadest industry-focused event on this list, bringing together stakeholders from across women’s health for two days at the Emirates Stadium in London.

Rather than concentrating on one condition or treatment, the event is geared towards the bigger picture: how innovation in women’s health can be funded, developed, scaled and integrated into healthcare systems.

For 2026, the programme has doubled in size, with two stages designed to accommodate both global, system-level discussions and practical advice for scaling women’s health businesses.

Networking and matchmaking are also a significant part of the proposition, with the event designed to connect founders and early-stage companies with investors, corporates, providers, government and other potential partners.

For those working commercially or strategically in women’s health, this is likely to offer the widest view of where the sector is heading. 

When: 7–8 October 2026
Where: Emirates Stadium, London
Focus: Investment, innovation, partnerships and scaling women’s health

2. Women’s Circle 2.0 — 10–11 October, Somerset

Best for: Women interested in understanding their menstrual cycle, period health and the potential place of plant medicine in their wellbeing.

At the other end of the spectrum is Women’s Circle 2.0, an intimate two-day retreat limited to just 25 attendees.

Created by wellbeing platform Plantz, the second Women’s Circle will focus on “Women’s Health First”, with the menstrual cycle at the centre of conversations around hormones, period pain, endometriosis, PMDD, nutrition, exercise and plant medicine.

Medical cannabis will form part of the discussion, with sessions exploring the endocannabinoid system, routes of administration and patient education. Importantly, organisers say cannabis will not be presented as a catch-all solution, but as one potential tool which women may encounter as part of their individual health journey.

The format sets it apart from the larger conferences on this list. Alongside expert talks and Q&As, the weekend includes yoga, sound therapy, wild swimming, sauna sessions and opportunities for informal conversation.

For patients and women wanting an accessible introduction to menstrual health and plant medicine, it offers something very different from the clinical and business-led conferences that follow.

When: 10–11 October 2026
Where: Somerset, UK
Focus: Menstrual health, hormones, wellbeing and plant medicine

3. Her Medicine — 19 October, London

Best for: Patients, carers, healthcare professionals and those interested in patient-led approaches to women’s health and medical cannabis.

Her Medicine places patient experience firmly at the heart of the conversation.

Hosted by We, The Patients and PatientsCann UK at London’s Foundling Museum, the free event is designed as an inclusive space bringing together clinical perspectives, holistic wellbeing and community support.

Expert talks and panels will explore women’s health, treatment access and navigating healthcare, with speakers including Dr Shabnam Sarshar, Dr Callie Seaman, Dr Michelle Nyangereka and Dr Wendy Holden.

There is also a strong practical and community element. The programme includes an interactive terpene workshop and sound bath, while medical cannabis patients will have access to a private, ventilated space in which to administer their prescribed medication.

Its free admission also makes it one of the most accessible events on the calendar.

When: 19 October 2026
Where: The Foundling Museum, London
Focus: Patient experience, women’s health, medical cannabis and community care

 

4. Cannabis Health Symposium Frankfurt — 4 November, Frankfurt

Session to watch: Endometriosis and Beyond: Medical Cannabis in Women’s Health

Best for: Clinicians, researchers, medical cannabis professionals and patient advocates interested in the emerging evidence around cannabinoids and women’s health.

Women’s health is one part of a wider clinical and industry programme at the Cannabis Health Symposium Frankfurt, rather than the sole focus of the conference.

However, a dedicated session, Endometriosis and Beyond: Medical Cannabis in Women’s Health, will see Dr Shabnam Sarshar and physician and gynaecologist Sylvia Mechsner examine what is currently understood about cannabinoids in endometriosis and other areas of women’s health.

Around two million women in Germany are estimated to live with endometriosis, while diagnosis can still take eight to 10 years. Against that backdrop, patients are already reporting using cannabis to manage symptoms, despite significant gaps in the clinical evidence.

The discussion will examine research involving more than 900 German-speaking endometriosis patients, alongside the potential role of the endocannabinoid system in endometriosis-related pain.

Crucially, it will also interrogate the limitations of the evidence. Questions around sex differences in cannabinoid pharmacology, the potential impact of hormonal status and cycle phase on treatment response, and the lack of female-specific clinical data remain largely unanswered.

When: 4 November 2026
Where: Mainhaus, Frankfurt
Focus: Endometriosis, cannabinoid medicine, evidence gaps and female-specific research

5. Cannabis Health Symposium London — 26 November, London

Session to watch: Addressing unmet needs in women’s health

Best for: Healthcare professionals, prescribers, researchers, industry and patient advocates looking for a multidisciplinary discussion of medical cannabis in women’s health.

Women’s health will also feature prominently when the Cannabis Health Symposium returns to London in November.

As with Frankfurt, this is a wider medical cannabis conference, covering policy, regulation, access, clinical practice and research, with women’s health forming a dedicated part of the programme.

The multidisciplinary panel Addressing unmet needs in women’s health will look across menopause, endometriosis, PMDD, chronic pelvic pain and related conditions where patients may be seeking cannabis-based medicines after conventional approaches have failed to adequately manage their symptoms.

Rather than focusing on a single diagnosis, the discussion will examine the evidence across several areas of unmet need, drawing on clinical experience and identifying priorities for future research.

For clinicians in particular, the focus will be on understanding both the potential and the limitations of the existing evidence, rather than presenting medical cannabis as an established solution for women’s health conditions.

When: 26 November 2026
Where: Conway Hall, London
Focus: Medical cannabis, menopause, endometriosis, PMDD and chronic pelvic pain

6. Mind Forward — 1 December, London

Session to watch: 2% of the Funding for 51% of the Population: Is Women’s Mental Health Underserviced?

Best for: Mental health professionals, researchers, founders, investors and those interested in emerging therapeutics and female-specific mental health research.

Closing out the calendar is Mind Forward, a new conference focused on the science, research, and innovation shaping the future of brain and mental healthcare.

Women’s health is not the sole focus of the event. Instead, a dedicated session will ask why women’s mental health remains underserved — and what researchers, innovators and investors are doing to address it.

Moderated by New Scientist’s Claudia Canavan and featuring neuroscientist and Hystelica founder Dr Grace Blest-Hopley, the discussion will explore the historic lack of female representation in research and what that means for treatment today.

The session will range from hormone-informed psychedelic research and cycle-aware digital therapeutics to funding and the development of treatments which account for female biology from the outset.

Mind Forward places the issue within a much broader conversation about neuroscience, mental health innovation and emerging therapeutics.

When: 1 December 2026
Where: Ministry of Sound, London
Focus: Women’s mental health, psychedelics, digital therapeutics, research and investment

 

Which women’s health event is right for you?

Despite sharing a focus on women’s health, these events approach the subject from markedly different directions.

For industry leaders, founders and investors, Women’s Health Week Europe offers the broadest overview of the commercial and systemic women’s health landscape, with a strong emphasis on partnerships, investment and scaling innovation.

For patients and those seeking community and practical education, Women’s Circle 2.0 and Her Medicine provide more accessible, patient-centred environments.

For clinicians and medical cannabis professionals, the Frankfurt and London Cannabis Health Symposia offer a deeper dive into the evidence — and its limitations.

Mind Forward widens the lens beyond cannabis, asking how mental health research, psychedelics, technology and investment can better account for female biology.

While the events differ significantly in their audiences and approaches, they collectively ask a common question. What would healthcare look like if women’s experiences — and female biology — were considered from the outset?

News Editor

News Editor

Evidence-led reporting on cannabis science, medicine and policy across the UK and Europe.